Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices-Reference-Cited by-同舟云学术

Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices

Published:2021-12 Issue: Volume: Page:
ISSN:1547-5271
Container-title:Heart Rhythm
language:en
Short-container-title:Heart Rhythm

Author:

Lee Justin Z.^ORCID,Majmundar Monil,Kumar Ashish,Thakkar Samarthkumar,Patel Harsh P.,Sorajja Dan,Valverde Arturo M.,Kalra Ankur,Cha Yong-Mei,Mulpuru Siva K.,Asirvatham Samuel J.,Desimone Christopher V.,Deshmukh Abhishek J.

Publisher

Elsevier BV

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Trends in permanent pacemaker implantation in the United States From 1993 to 2009: increasing complexity of patients and procedures;Greenspon;J Am Coll Cardiol,2012

2. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006;Kurtz;Pacing Clin Electrophysiol,2010

3. Trends of cardiovascular implantable electronic device infection in 3 decades: a population-based study;Dai;JACC Clin Electrophysiol,2019

4. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction;Kusumoto;Heart Rhythm,2017

5. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE)

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indications for Lead Extraction;Cardiac Electrophysiology Clinics;2024-09

2. Automated electronic alert for the detection of infected cardiovascular implantable electronic devices in patients with bacteremia;Heart Rhythm;2024-07

3. Trends and disparities in cardiac implantable electronic device infection‐related mortality in the United States;Journal of Cardiovascular Electrophysiology;2024-05-09

4. Comparison of infection and complication rates associated with transvenous vs. subcutaneous defibrillators in patients with stage 4 chronic kidney disease: a multicenter long-term retrospective follow-up;Frontiers in Cardiovascular Medicine;2024-04-10

5. Cardiac implantable electronic devices and bloodstream infections: management and outcomes;European Heart Journal;2024-03-28